About 100 reports

  • CANCER GENE THERAPY IN AMERICAS
  • High cost of gene therapy treatment

About Cancer Gene Therapy Cancer gene therapy is the treatment of cancer through gene therapy. The therapy uses genetically engineered vectors mostly viruses to deliver a gene into the individual’s body. It can be used for both the prevention and treatment of disease. The major therapies used for the treatment are oncolytic virotherapy,...

  • Gene Therapy
  • World
  • Forecast
  • Market Size
  • Celgene Corporation

Global & US Gene Therapy Market Forecast to 2020 ##.

  • Biological Therapy
  • Gene Therapy
  • United States
  • World
  • Market Size
  • OVERVIEW: GENE THERAPY FOR HEMOPHILIA
  • OVERVIEW: GENE THERAPY FOR HEMOPHILIA A

Hemophilia Gene Therapy: An insight Hemophilia is an inherited bleeding disorder. The gene responsible for hemophilia is present on the X chromosome and is inherited in a recessive manner. Hemophilia A, also called as factor VIII (FVIII) deficiency or classic hemophilia, is caused by missing or defective factor VIII. Most individuals,...

  • Gene Therapy
  • Alnylam Pharmaceuticals, Inc.
  • Baxter International Inc.
  • Pharming Group NV
  • uniQure N.V.

As gene therapies are generally meant for one time or short duration treatments, they are customized to individuals confined to small patient populations.

  • Biological Therapy
  • Gene Therapy
  • Therapy
  • World

Cancer Gene Therapy Market - Global Opportunity Analysis and Industry Forecast, 2017-2023 CHAPTER ## INTRODUCTION ##. ##.

  • Cancer Gene Therapy
  • Gene Therapy
  • APAC
  • World
  • Market Size
  • GENE THERAPY
  • GENE THERAPY

INTRODUCTION The concept of gene transfer into mammalian cells can be traced back to the 1920s. However, the first gene therapy, Gendicine®, was only approved in 2003 in China; since then, the domain has evolved significantly. The year 2017 was particularly eventful; despite the withdrawal of Glybera® from the European...

  • Gene Therapy
  • North America
  • United States
  • Company
  • Market Size
  • Mucopolysaccharidoses gene therapy molecules by disease type
  • ASSESSMENT OF GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS BY STAGE AND ROA

This pipeline analysis report provides detailed insights into the clinical trials landscape of the gene therapy for mucopolysaccharidosis including molecules at pre-clinical and various other development stages. The report also offers comprehensive information about the therapeutic assessment of the pipeline molecules based on various segmentations...

  • Gene Therapy
  • Therapy
  • United States
  • Abeona Therapeutics, Inc.
  • RegenxBio Inc.
  • Ovarian cancer gene therapy: An overview of pipeline
  • Ovarian cancer gene therapy molecules by type of ovarian cancer

This pipeline analysis report provides detailed insights into the clinical trials landscape of the gene therapy for ovarian cancer including molecules at various development stages. The report also offers comprehensive information about the therapeutic assessment of the pipeline molecules based on various segmentations such as route of administration...

  • Gene Therapy
  • United States
  • Advantagene, Inc.
  • Celsion Corporation
  • Takara Bio Inc.

Gene Therapy Market - Global Opportunity Analysis and Industry Forecast, 2017-2023 CHAPTER ##: INTRODUCTION ##. ##.

  • Biological Therapy
  • Gene Therapy
  • Market Size

Global Gene Therapy Market Forecast to 2020 ##.

  • Biological Therapy
  • Gene Therapy
  • World
  • Market Size

Gene Therapy Market by Vector Type, Gene Type and Applications - Global Opportunity Analysis and Industry Forecast, 2017-2023 CHAPTER ##: INTRODUCTION ##. ##.

  • Biological Therapy
  • Gene Therapy
  • Market Size

Gene Therapy: Moving Towards Commercialization Table of Contents Executive Summary vi The potential near-term success of ex vivo gene therapies xxii Outlook for gene therapy xxv CHAPTER ##: History of Gene Therapy ## Ear

  • Biological Therapy
  • Gene Therapy

The current pipeline for gene therapies is diverse in terms of the approaches and vectors covered; ##% are gene silencing therapies, while ##% involve the insertion of a functional gene - - In which therapy areas is there the highest level of R&a

  • Biological Therapy
  • Gene Therapy
  • Market Size
  • European Cell and Gene Therapies Market
  • European Cell and Gene Therapies Market

In the year 2015, the global market for biopharmaceuticals was valued at USD 176.9 billion. It is estimated at USD 192.2 million for the year 2016 and is projected to reach USD 291 billion by the year 2021. The estimated CAGR during the forecast period (2016-2021) is 8.6%. Current trends in biopharmaceuticals market: On...

  • Gene Therapy
  • World
  • Market Size
  • Merck & Co., Inc.
  • Takeda Pharmaceutical Company Limited

Glybera, a gene therapy for lipoprotein lipase deficiency, was recently launched in Germany at a price of more than ## million euros ($##. ## million).

  • Biological Therapy
  • Gene Therapy
  • Europe
  • European Union
  • United States

Global Gene Therapy Market & Pipeline Insight ##.

  • Biological Therapy
  • Gene Therapy
  • World
  • Market Size

Gene Therapy Pipeline Molecules ##.

  • Gene Therapy
  • APAC
  • World
  • Forecast
  • Market Size
  • 9.7 BENITEC BIOPHARMA LTD
  • 7.4 REST OF THE WORLD

RNAi Technology Market The market for RNAi technology is estimated to be USD 12.56 billion in 2016 and is expected to reach USD 31.52 billion by 2021, growing at a CAGR of 20.19% RNA interference (RNAi) is a natural process of treating forms of cancer and other diseases by post-transcriptional silencing of genes by small fragments...

  • Gene Therapy
  • World
  • Alnylam Pharmaceuticals, Inc.
  • Arcturus Therapeutics, Inc.
  • Sirna Therapeutics, Inc.

How familiar they are with gene therapy What they perceive to be the key benefits of gene therapy?

  • Gene Therapy
  • Psychotic Disorder
  • Therapy
  • United States
  • World
  • GENE THERAPY VECTORS: DOSAGE FREQUENCY
  • OPEN GENE THERAPY TRIALS: DISTRIBUTION BY PHASE OF DEVELOPMENT

INTRODUCTION Gene therapy has emerged as a promising treatment option for various diseases (primarily the ones that currently have no cure) including cancers, inherited disorders and some viral infections. Gene therapies and genetically modified therapies involve the introduction of therapeutic DNA (gene of interest) into the patient’s...

  • Gene Therapy
  • United States
  • Market Size
  • Supply
  • MolMed S.p.A.

High cost associated with gene therapies ##. ##. ##. ##.

  • Biological Therapy
  • Gene Therapy
  • Viral Vector
  • Market Size
  • GENE THERAPIES, GLOBAL, DEFINITION OF GENE THERAPY, 2017
  • Currently Approved Gene Therapies

Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis Summary GBI Research’s latest report: “Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect...

  • Biological Therapy
  • Gene Therapy
  • World
  • Deals & Alliance
  • Supply

(USA) ##.

  • DNA
  • Gene Therapy
  • Genomics
  • World
  • Market Shares
  • MARKETED CELL / GENE THERAPIES: PRICE
  • CELL THERAPY MANUFACTURING: CONTRACT MANUFACTURERS

INTRODUCTION The concept of immunotherapies dates back to the 18th century; however, since inception, the field has evolved tremendously and is currently cited as one of the most rapidly growing segments of the pharmaceutical industry. Harnessing immune system components for developing therapeutic solutions has demonstrated significant...

  • Gene Therapy
  • North America
  • United States
  • Juno Therapeutics Inc.
  • Kite Pharma, Inc.

Cancer Gene Therapy Market Analysis ##.

  • Biological Therapy
  • Cancer
  • Cancer Gene Therapy
  • Gene Therapy
  • Pathology
  • GENE THERAPY
  • GENE THERAPY RESEARCH INSTITUTION

The Global Gene Therapy Partnering Agreements 2010-2018 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in gene therapy partnering deals Disclosed headlines, upfronts, milestones and royalties by stage...

  • Eye Disease
  • Gene Therapy
  • Therapy
  • United States
  • uniQure N.V.
  • 9. Background
  • 8. Latest update

Synopsis "PFE – Gene Therapy Manufacturing Facility – North Carolina - Project Profile" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key...

  • Biological Therapy
  • Construction
  • Gene Therapy
  • United States
  • Company Operations
  • Gene therapy for AMD: An overview of pipeline
  • Gene therapy pipeline candidates for AMD by company

This pipeline analysis report provides detailed insights into the clinical trials landscape of the gene therapy molecules for age-related macular degeneration in the development and pre-clinical stages. The report also offers comprehensive information about the therapeutic assessment of the pipeline molecules based on various segmentations...

  • Gene Therapy
  • Therapy
  • United States
  • World
  • Oxford BioMedica plc
  • GENE THERAPY
  • GENE THERAPY PIPELINE

“Congestive Heart Failure (CHF) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of CHF. The report covers all the drugs being developed in various development phases (Discovery to Phase 2 clinical). The pipeline focuses on disease modification and includes pharmacologic drugs, gene therapy,...

  • Gene Therapy
  • Bioheart, Inc.
  • Celladon Corporation
  • GlaxoSmithKline plc
  • Juventas Therapeutics, Inc.

Additionally, increasing focus on R& D of gene delivery systems owing to the high growth potential of gene therapy for the treatment of a wide range of diseases is expected to fuel the market growth in the future.

  • Drug Delivery
  • Gene Therapy
  • Nanotechnology-Based Drug Delivery
  • United States
  • Forecast